Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European...
The listing on one of the world’s largest global cryptocurrency exchanges expands market access and secondary liquidity for Enlivex’s primary...
Smaller 5-millimeter instruments to be incorporated into the SSi Mantra surgical robotic systemFORT LAUDERDALE, Fla., Jan. 06, 2026 (GLOBE NEWSWIRE)...
FSdC demonstrated statistically significant and superior improvement in disc preservation and structural integrity compared to other treatmentsHOUSTON, Jan. 05, 2026...
Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to aid in detection and...
Neither study achieved its primary endpoint of reduction in annualized clinical fracture rate compared to placebo (Orbit) or bisphosphonates (Cosmic)...
"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within the timelines required by law,...
This Christmas season, President Trump's executive action to advance rescheduling and medical research has finally exposed the truth: the DEA...
Sanofi provides update on tolebrutinib regulatory submission in non-relapsing secondary progressive multiple sclerosis Paris, December 24, 2025. The US Food...
Initial modules submitted to FDA under rolling review; final modules expected in the first half of 2026CANTON, Mass., Dec. 23,...
FDA qualification of Total Hip BMD as a validated surrogate endpoint for novel osteoporosis drug development further bolsters Entera's July...
Findings show Linus Health's AI can indicate Alzheimer's pathology before noticeable symptoms—enabling earlier action to help protect independence and preserve...
Despite decades of research, many COPD subpopulations remain poorly understood in real-world settings and underserved by existing therapiesUsing AI to...
Despite decades of research, many COPD subpopulations remain poorly understood in real-world settings and underserved by existing therapiesUsing AI to...
Brainomix 360 Stroke imaging was utilized to improve and standardize the grading of baseline stroke severity, prior to treatment in...
-- Following positive efficacy and safety results from Phase 2b QUALITY study, company received FDA regulatory clarity for enobosarm in...
WEST DES MOINES, Iowa, Dec. 16, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced today the expansion of its Partner Ecosystem, strengthening...
WEST DES MOINES, Iowa, Dec. 16, 2025 /PRNewswire/ -- Navigate Wellbeing Solutions announced today the expansion of its Partner Ecosystem, strengthening...
Atlanta, Georgia--(Newsfile Corp. - December 15, 2025) - Apyron, Inc. is a medical technology company with a product portfolio designed...
GENEVA, SWITZERLAND / ACCESS Newswire / December 15, 2025 / MindMaze Therapeutics Holding SA (SIX:MMTX) (MindMaze Therapeutics or the Company)...